Newsroom

NEW YORK--(BUSINESS WIRE)--Everest Business Funding, a leading provider of fast and flexible financing solutions for small businesses nationwide, continues to empower entrepreneurs by helping them access the capital they need to grow and operate with confidence. Through their streamlined funding process and relationship-driven approach, Everest Business Funding has supported countless business owners across a wide range of industries, including Bakersfield Car Audio and Stereo, a locally owned...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 02.01.2026 UIGB IE00079WNSI6 16,334.00 GBP 390,578.54 23.912  ...

LONDON--(BUSINESS WIRE)--Phillips 66 Limited has agreed to acquire Lindsey Oil Refinery assets and associated infrastructure....

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical has entered into a Memorandum of Understanding (MoU) for capital investment and strategic alliance with OrangeTwist...

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference....

OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of rusfertide for the treatment of adults with polycythemia vera (PV). Rusfertide is an investigational first-in-class subcutaneously administered hepcidin mimetic peptide designed to regulate iron homeostasis and red blood...

SILVER SPRING, Md. & DURHAM, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will present a company overview and update on Monday, January 12, 2026, from 1:30 to 2:10 p.m. PST, at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations. An ar...

NEW YORK & TEL AVIV--(BUSINESS WIRE)--Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, today announced it will participate in the 28th Annual Needham Growth Conference on January 14th in New York. Tal Jacobson, CEO, and Elad Tzubery, CFO, will host one-on-one meetings with investors. To request a meeting, please contact your representatives at Needham. Mr. Jacobson will also participate in a fireside chat at 9:30 am...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 02.01.2026 UNCU.LN IE00BD6GCF16 798,869.00 USD 33,220,638.12 41.585  ...

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, in San Francisco. Gaurav Shah, M.D., Chief Executive Officer, is scheduled to present on Wednesday, January 14, at 11:15 a.m. PT and host investor meetings throughout th...